TAOKA CHEMICAL COMPANY,LIMITED

田岡化学工業

Industry: Chemicals
Market: Standard
Accounting standards: Japanese GAAP
Consolidation basis: Consolidated

Notes

Stock adjustments
Oct 1, 2021 Stock split 1 share → 5 shares

Key metrics

Revenue(million JPY)

Mar 2021

32,057

Mar 2022

32,374

Mar 2023

30,167

Mar 2024

28,544

Mar 2025

29,930

Operating profit(million JPY)

Mar 2021

4,016

Mar 2022

2,708

Mar 2023

451

Mar 2024

1,075

Mar 2025

1,887

Operating profit margin(%)

Mar 2021

12.53

Mar 2022

8.37

Mar 2023

1.5

Mar 2024

3.77

Mar 2025

6.3

Profit before tax(million JPY)

Mar 2021

3,663

Mar 2022

2,769

Mar 2023

478

Mar 2024

1,128

Mar 2025

1,963

Profit(million JPY)

Mar 2021

2,615

Mar 2022

2,064

Mar 2023

311

Mar 2024

820

Mar 2025

1,478

Total assets(million JPY)

Mar 2021

27,958

Mar 2022

32,418

Mar 2023

31,069

Mar 2024

29,720

Mar 2025

30,407

Cash and cash equivalents(million JPY)

Mar 2021

4,330

Mar 2022

719

Mar 2023

853

Mar 2024

972

Mar 2025

2,982

Cash flows from operating activities(million JPY)

Mar 2021

5,219

Mar 2022

-1,330

Mar 2023

1,478

Mar 2024

3,628

Mar 2025

4,371

Cash flows from investing activities(million JPY)

Mar 2021

-2,095

Mar 2022

-2,075

Mar 2023

-4,340

Mar 2024

-1,142

Mar 2025

-1,418

Cash flows from financing activities(million JPY)

Mar 2021

-680

Mar 2022

-274

Mar 2023

2,996

Mar 2024

-2,390

Mar 2025

-997

Return on equity(%)

Mar 2021

18.5

Mar 2022

12.9

Mar 2023

1.9

Mar 2024

4.9

Mar 2025

8.3

Equity ratio(%)

Mar 2021

54.5

Mar 2022

51.7

Mar 2023

53.3

Mar 2024

57.9

Mar 2025

60.8

Earnings per share(JPY per share)

Mar 2021

182.516

Mar 2022

144.03

Mar 2023

21.68

Mar 2024

57.26

Mar 2025

103.18

Net assets per share(JPY per share)

Mar 2021

1,063.44

Mar 2022

1,168.92

Mar 2023

1,156.45

Mar 2024

1,201.14

Mar 2025

1,291.05

Dividend per share(JPY per share)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Payout ratio(%)

Mar 2021

17.53

Mar 2022

24.99

Mar 2023

124.54

Mar 2024

31.44

Mar 2025

30.04

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.